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Summary In Britain the National Health Service Central Registers (NHSCRs) provide the facility for a
study population to be 'flagged', initiating a system of notification to investigators of deaths and cancers that
occur in the population. This system of notification is an invaluable resource for epidemiological research. A
comment on its efficiency is provided here by a comparison of the system with an independently ascertained
series of breast cancers.
Fifty verified breast cancer cases were identified during a study of a flagged cohort of British women taking
hormone replacement therapy. At the time of analysis (May 1985), some 2.5 years after diagnosis of the most
recent case, twenty-eight of the 50 cases had not been notified to the investigators by the NHSCRs. Of these,
fourteen had not been registered. Eight had been duly registered, but had not yet been recorded at the
NHSCRs. Five of the remaining six cases were in the process of being notified. The implications of these
findings for cancer researchers are discussed. The potential for omission and delay between the diagnosis of
cancers in a flagged population and their notification to the investigators must be taken into account, if
underestimation of the true level of cancer risk is to be avoided.
The National Health Service Central Registers (NHSCRs) in
Britain offer, with appropriate safeguards for confidentiality,
the facility of labelling or 'flagging' individuals in a defined
study population, thus providing a system of automatic
notification to a study investigator of deaths (since 1939)
and cancer registrations (since 1971) amongst study
participants. Their use in epidemiological studies of mortality
and cancer morbidity is well recognised and exploited
(Kinlen, 1980; OPCS, 1982), and they provide an invaluable
resource for epidemiologists in the UK.
Cancer registration is voluntary in the UK: twelve regional
cancer registries covering England and Wales aim to record
details of all new cancers in their territory, and report these
to the National Cancer Registration Scheme administered by
the Office of Population Censuses and Surveys (OPCS). The
five registries covering Scotland report separately to the
Scottish Cancer Registration scheme. Six of the cancer
registries employ peripatetic clerks who abstract hospital
records of cancer patients. Other registries use data derived
from the Hospital Activity Analysis (HAA) system, which
provides information on all hospital discharges and deaths
for administrative purposes: all HAA abstracts which include
a cancer as one of the diagnoses at discharge are abstracted
for the registry. All registries use more than one source of
information (Swerdlow, 1986).
When a registry acquires information about a patient with
cancer, details are checked against a master index to ensure
that the cancer is eligible for registration. The registries
forward this data on a regular basis to OPCS, where each
cancer registration is checked automatically for completeness
and validity. The national cancer file is then updated, and
copies of the registrations are forwarded to the NHSCRs,
where their receipt is noted in the record of each individual
concerned. If the individual has been 'flagged', the relevant
investigator is then notified. This process often involves
considerable delay: in recent years, the delay between cancer
registration and transmission to OPCS has varied from 6
months to as much as 3 years (Balarajan & Scott, 1983). The
delay between receipt of a batch of registrations by OPCS
and processing at NHSCR may also be as much as a year.
The reliability of this system of notification is of crucial
importance in studies which depend on the NHSCR to
identify cancers and deaths. The notification of deaths is
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regarded as being reliable and essentially complete, but there
is some concern about the completeness and timeliness of
cancer notifications (see, for example, OPCS, 1981;
Swerdlow, 1986). We report here the results of an
opportunistic study of the reliability of notification from the
NHSCRs of breast cancers in a cohort of long-term users of
hormone replacement therapy (HRT). We examine both the
extent of delay in receipt of notifications and other potential
weaknesses in the cancer registration system. We also discuss
the implications of these delays for studies of cancer
morbidity which depend on the NHSCR system for case
identification.
Methods
The main study population from which the cases in this
report are derived is a cohort of 4544 women who have
taken HRT, and in whom mortality and cancer incidence are
being monitored. These women were recruited from specialist
menopause clinics around Britain and had taken at least one
year's continuous therapy at the time of recruitment. Most
of the study population were recruited from London-based
clinics. The cohort was flagged at the NHSCRs in Southport
and Edinburgh during the period 1978-82. The main results
of the study are given elsewhere (Hunt et al., 1987).
In addition to routine cancer notification from the
NHSCRs, information about cancers was available to us
both from the participating clinics and from a postal
questionnaire mailed in the summer of 1984, which yielded
self-reported morbidity. Each report of a diagnosis of breast
cancer was followed up through the relevant medical
practitioner, regardless of its source, and information
sufficient to allow clinical staging of the breast cancer from
the medical records was sought in each case. The diagnosis
was histologically confirmed as primary carcinoma of the
breast in all except one case, in which palliative radiotherapy
had been given for advanced local disease without biopsy
evidence. We were thus able to ascertain how many of the
breast cancers identified either through the clinics or from
the questionnaire had not also been identified by notification
from the NHSCR ('unnotified' cases). For each 'unnotified'
case an attempt was made to trace the cancer through the
GPs, hospitals, cancer registries, OPCS and the NHSCRs to
investigate reasons for delay or failure of the system.
In all, 50 breast cancer cases were identified up to the end
of 1982, the closing date for the analysis (Hunt et al., 1987).
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Table I Details of breast cancers registered by May 1985 but not notified to investigators
Delay
Registry of Date of between diagnosis
Case no. residence Hospital diagnosis and registration
2 Yorkshire General Infirmary, Leeds 1975 Less than 1 year
3 S Thames Royal Marsden Hospital Jan 1976 Less than 1 year
15 S Thames Royal Marsden Hospital Jun 1981 3 years
19 W Midlands County Hospital, Hereford Mar 1982 Less than 1 year
21 S Thames Royal Marsden Hospital Apr 1982 2 years
22 S Thames Royal Marsden Hospital Jun 1982 2.5 years
23 S Thames Dulwich Hospital Sep 1982 1.5 years
26 W Midlands Birmingham General Hospital Nov 1982 Less than 1 year
Notification from the NHSCR (either a cancer registration
or a death certificate mentioning breast cancer) had been
received for only 22 of these cases at the time of analysis
(May 1985), 2.5 years after the closing date. Some of the
'unnotified' cases had been diagnosed shortly before the
closing date, and did not raise immediate doubts about the
reliability of cancer notification through the NHSCRs, but
15 had been diagnosed more than four years before the
analysis was undertaken.
We decided to pursue all 28 'unnotified' cases, to
determine if there had been any systematic failure in the
notification system. The NHSCRs were asked to check that
there was no record of a cancer registration for each of these
28 women. The appropriate cancer registry was also asked to
check if and when each case was registered. Several women
had received treatment within a cancer registry territory
other than that of their residential address: in such cases
both registries were approached for information. The
distribution of the dates of diagnosis was then compared for
'notified' and 'unnotified' cases. We also attempted to
discover why some cases had not been registered at all.
Results
Of 50 breast cancers (diagnosed 1973-82) identified by the
time of analysis in May 1985, 28 had not been notified to us
by the NHSCRs. There was no evidence that these cases
were simply the most recently diagnosed: rather the reverse.
One woman's record had not been traced for flagging at the
NHSCR, and her cancer, though registered at OPCS, could
thus not have been notified to us in any case*. Of the
remaining 27 cases, five were already being processed at the
NHSCRs in May 1985, and were immediately notified to us
in direct response to our query: they would presumably have
been included in the next quarterly mailing from the
NHSCRs. Eight cases had been registered and passed to
OPCS, but had not yet been forwarded to the NHSCRs.
Fourteen cases had not been registered at all.
Table I gives details of the eight cancers which had been
registered by May 1985 but not notified to us. The median
delay between diagnosis of the cancer and its registration at
the regional cancer registry was 1.0 years (range 0-3.0 years).
Six of these cancers were registered in 1982 or later, and
would probably have been notified to us by the NHSCRs in
due course. Two cases had been registered more than 10
years before the data were analysed, but the cancer had not
been entered in the woman's record at the NHSCR.
Details of the 14 cases which were not even registered by
May 1985 are given in Table II. The shortest interval
between the diagnosis of these cancers and our initial query
to the registry was 2.5 years, so all 14 cases must be
regarded as failures of cancer registrationt. There is no
single explanation for these failures, but it may be worth
noting that three patients were treated mainly or entirely in
private hospitals (nos. 6, 11 and 13), four were not resident
in the region in which they were treated, and six were treated
at more than one hospital. Some cases fall into more than
one of these categories. Eight of the 14 unregistered breast
cancers were treated entirely or partly in the Royal Marsden
Hospital, a specialist cancer referral centre in the South
Thames region. Although four of these women were not
resident in the region, all of them should have been recorded
in the South Thames Cancer Registry.
Table 1I Details of breast cancers not registered by May 1985
Case Registry of Registry of Year of
no. residence treatmenta Hospital(s) diagnosis
I W Scotland Stobhill 1974
4 S Thames RMHb 1976
5 S Thames Kingston 1978
RMH
6 S Thames NW Thames K Edward VII 1978
Middlesex
7 S Thames RMH 1979
8 NW Thames St Alban's 1979
RMH
9 Wessex S Thames RMH 1980
10 S Thames Royal Surrey 1980
St Luke's
11 Mersey S Thames Florence 1980
Nightingale
RMH
13 NW Thames Florence 1980
Nightingale
14 NE Thames S Thames RMH 1981
18 S Thames Bromley 1982
King's College
25 S Thames RMH 1982
28 NW Thames W Middlesex 1982
alf different from registry of residence; bRMH =Royal Marsden
Hospital.
Discussion
*Some 2-4% of cancer registrations received by NHSCR cannot
be linked with an individual's record. When a study cohort is first
flagged at NHSCR, these 'untraced' cancer registrations are checked
against all individuals in the cohort (Swerdlow, 1986), including
those who cannot be traced for flagging. However, any cancer
registrations which are received after the initial flagging of the
cohort and which cannot be linked to an individual's record are not
checked in this way; the labour of doing this for all the cohorts
flagged at NHSCR would be prohibitive.
The reason for conducting this exercise was the observation
that, at the time of analysis, fewer than half of the 50 breast
cancers identified in the main study had been notified to the
investigators by the NHSCRs. Thus, if we had relied solely
tTen cases were registered after our enquiries. The four NW and
NE Thames cases will not be registered unless the cancer is
mentioned on the death certificate, in which case it may be
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on the NHSCRs for case identification at this stage in the
cohort study, we might have reached a very different
conclusion about the potential effect of HRT on breast
cancer. With the same closing date for analysis, December
1982, we would have obtained a relative risk of 0.70, i.e. 22
observed vs. 31.38 expected, instead of the significantly
increased relative risk (1.59) obtained from all 50 verified
cases actually included in the analysis. We analysed our data
2.5 years after the closing date: if we had waited a further
year, say, it is possible, but by no means certain, that 33 of
the 35 registered cancers would have been notified to us. We
would then have obtained, at most, a non-significant relative
risk of 1.05 (33 observed vs. 31.38 expected). Some of the
unregistered cases might also have been notified to us at
death, provided breast cancer was mentioned on the death
certificate.
Several recent studies have addressed the issue of the
completeness of cancer registration in Britain. Some of these
(Nwene & Smith, 1982; Benn et al., 1982) have looked at
one cancer registry only, whilst others have assessed the
national situation (Swerdlow, 1986; Balarajan & Scott, 1983).
There is evidence to suggest that the regional registries vary
in their completeness of registration (Swerdlow, 1986), and
Donnan (1982) suggests that completeness for the 'less well-
served registries' may be as low as 60-70%. although the
basis for these figures is unclear. Two studies which have
provided estimates for the completeness of breast cancer
registration in the North Western Cancer Registry reported
figures of 84% (Benn et al., 1982) and 93% (Nwene &
Smith, 1982).
In this study we have provided some data on
incompleteness and delays in both the cancer registration
system and the process of notifying cancer cases to
researchers studying populations flagged at the NHSCRs. Of
50 breast cancers, only 36 (72%) had been registered. This
figure cannot be taken as an estimate of the completeness of
breast cancer registration nationally, since it is based on a
small number of cases which are not a nationally
representative sample. Nor is it possible to comment on
particular cancer registries. Most of the women in our study
population were recruited from London clinics, and our
breast cancer cases involved the Thames registries more
often than if they had been a national sample. Even in the
Thames registry our cases were not regionally representative,
involving the Royal Marsden Hospital three times as often
as expected. This hospital serves the SW Thames region,
which has the highest standardised registration ratio for
breast cancer (115) of all the English health regions (OPCS,
1986). Despite these caveats, the failure to register 14 of the
5() breast cancers is still disturbing.
Several conclusions may be drawn. Investigators carrying
out long-term follow-up studies which depend on the
NHSCRs for ascertainment of cancer in their study
population should be aware of the often considerable delay
between a diagnosis of cancer and its eventual notification to
the investigators. This delay may vary for different registries
and for different cancers. There is some evidence, for
example, that breast cancer is more prone to be registered
late than cancers at other sites (Swerdlow, 1986). We suggest
that unless and until cancer registration, flagging and
notification can be made substantially more prompt, the
closing date for national studies should be at least three and
perhaps five years earlier than the date on which analysis
begins - otherwise there is a real chance of failing to include
cancers registered more recently, and consequently, of under-
estimation of any true risk. For studies of populations
resident in the territory of only one or a few cancer
registries, the closing date should be chosen in the light of
the mean delays between diagnosis, registration and
submission of data to OPCS in those registries; these delays
may well vary for different cancer sites.
Finally, it should be clear that if cancer registration data
are to be exploited to the full, then both collection and
dissemination of these data need to be prompt, accurate and
complete. This imposes a very considerable burden of work
on the regional cancer registries.
There is no question that both the cancer registries and
the National Health Service Central Registers provide a
valuable service. However, it is only by clarifying the
limitations of the cancer registration scheme that improve-
ments can be made. Our main aim is to draw the attention
of other researchers to some potential weaknesses in the
current system of cancer notification in flagged cohorts, and
to point out the possibility of underestimating the true risk
of incident cancer if the weaknesses are not sufficiently taken
into account.
We gratefully acknowledge the cooperation and assistance we have
received from all the cancer registries and hospital medical records
officers who helped in our attempts to trace the breast cancer cases
for this report. We also acknowledge the invaluable assistance of the
National Health Service Central Registers in Southport and
Edinburgh, without which the main study on which this report is
based would have been impossible. We thank Martin Vessey, Klim
McPherson, Leo Kinlen, Sir Richard Doll and Malcolm Pike for
helpful comments.
References
BALARAJAN, R. & SCOTT, A. (1983). National cancer registration:
An appraisal. Conmm. Med., 5, 31.
BENN, R.T., LECK, 1. & NWENE, U.P. (1982). Estimation of
completeness of cancer registration. Int. J. Epidemiol., 11, 362.
DONNAN, S. (1982). Cancer registration - advance or retreat? In
Recent 4dvances in Community Medicine, 2. Smith, A. (ed),
Churchill Livingstone: Edinburgh.
HUNT, K., VESSEY, M.P., McPHERSON, K. & COLEMAN, M.P. (1987).
Long-term surveillance of mortality and cancer incidence in
women receiving hormone replacement therapy. Br. J. Obstet.
Gynaecol., (in press).
KINLEN, L.J. (1980). The death registration system and the National
Health Service Register in Britain: Their value to epidemiological
research. In Cancer Incidence in Defined Populations, Banbury
Report No. 4, p. 437. Cold Spring Harbor Laboratory.
NWENE, U. & SMITH, A. (1982). Assessing completeness of cancer
registration in the North-western region of England by a method
of independent comparison. Br. J. Cancer, 46, 635.
OFFICE OF POPULATION CENSUSES AND SURVEYS (1981). Report
of the Advisory Committee on Cancer Registration: Cancer
Registration in the 1980s. Series MB1, no. 6. HMSO: London.
OFFICE OF POPULATION CENSUSES AND SURVEYS (1982). The
National Health Service Central Register as an aid to medical
research: A guidefor potential applicants. HMSO: London.
OFFICE OF POPULATION CENSUSES AND SURVEYS (1986). Cancer
statistics: Registrations: England and Wales, 1983. Series MBI,
no. 15. HMSO: London, 1986.
SWERDLOW, A.J. (1986). Cancer registration in England and Wales:
Some aspects relevant to interpretation of the data. J. R. Statist.
Soc. A., 149, (part 2), 146.
WATERHOUSE, J.A.H. (1982). UK, England, Birmingham and West
Midlands Region. In Cancer Incidence in Five Continents (IV),
Waterhouse, J. et al. (eds) p. 550. IARC: Lyon.